Independent Research set a €80.00 ($93.02) price target on Gerresheimer (ETR:GXI) in a research note published on Monday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
GXI has been the subject of several other research reports. Berenberg Bank reaffirmed a buy rating and set a GBX 100 ($1.31) price objective on shares of in a research report on Thursday, July 11th. Deutsche Bank raised their price objective on shares of Spirit Airlines from $75.00 to $79.00 and gave the stock a buy rating in a research report on Friday, July 12th. Credit Suisse Group set a $5.00 price objective on shares of Maxar Technologies and gave the stock a sell rating in a research report on Monday. JPMorgan Chase & Co. set a GBX 3,200 ($41.81) price objective on shares of Diageo and gave the stock a neutral rating in a research report on Wednesday, July 10th. Finally, Kepler Capital Markets set a €19.00 ($22.09) price objective on shares of Rhoen Klinikum and gave the stock a sell rating in a research report on Thursday, April 11th. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. Gerresheimer presently has an average rating of Hold and a consensus price target of €70.17 ($81.60).
Shares of GXI stock opened at €72.55 ($84.36) on Monday. The firm has a market cap of $2.28 billion and a P/E ratio of 11.00. Gerresheimer has a 52 week low of €51.10 ($59.42) and a 52 week high of €80.25 ($93.31). The company has a current ratio of 0.85, a quick ratio of 0.56 and a debt-to-equity ratio of 64.56. The stock’s 50 day moving average is €65.82.
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Further Reading: How much money do you need to begin day trading?
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.